Related Experiment Video
Updated: Oct 11, 2025

Sectioning Mammary Gland Whole Mounts for Lesion Identification
Published on: July 24, 2017
Pyroptosis: the pathological process that dominates granulomatous lobular mastitis
1Department of General Surgery, Dongzhimen Hospital of Beijing University of Chinese Medicine, Beijing, China.
This study reveals that pyroptosis, a form of programmed cell death, is crucial in the pathogenesis of granulomatous lobular mastitis (GLM). Targeting pyroptosis may offer new therapeutic strategies for GLM.
Area of Science:
- Pathology
- Molecular Biology
- Cellular Biology
Background:
- Granulomatous lobular mastitis (GLM) is an inflammatory breast condition with complex pathogenesis.
- Understanding the cellular mechanisms underlying GLM is essential for developing effective treatments.
Purpose of the Study:
- To investigate the role of pyroptosis in the pathogenesis of granulomatous lobular mastitis (GLM).
- To explore the expression of key pyroptosis markers, caspase-1 and gasdermin D (GSDMD), in GLM tissues.
Main Methods:
- Pathological examination of GLM tissue samples from 28 patients.
- Western blot and immunohistochemistry to quantify caspase-1 and GSDMD expression.
- Transmission electron microscopy (TEM) to analyze cellular ultrastructure.
Main Results:
- Significantly increased expression of activated caspase-1 and GSDMD in GLM lesions compared to controls (P < 0.05).
- TEM confirmed distinct features of pyroptosis in the affected tissues.
- Evidence suggests pyroptosis plays a role in GLM development and may inhibit apoptosis.
Conclusions:
- Pyroptosis is a key pathway implicated in the pathogenesis of granulomatous lobular mastitis.
- The findings suggest that targeting pyroptosis could be a potential therapeutic avenue for GLM treatment.
More Related Videos
08:51Intraductal Injection of LPS as a Mouse Model of Mastitis: Signaling Visualized via an NF-κB Reporter Transgenic
Published on: September 4, 2012
06:12Author Spotlight: THP-1 Macrophage Response to LPS/ATP — Unveiling the Pyroptosis, Apoptosis, and Necroptosis Spectrum
Published on: May 3, 2024
Related Concept Videos
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pneumonia II: Pathophysiology
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories: